Ocugen, Inc. Net Income Loss

• Ocugen, Inc. showed a decrease of -25.5% in Net Income Loss from 2024 to 2025.
• This data is from Ocugen, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
• XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2014: -$8.30 million | Q3 2014: -$11.97 million | Q1 2015: -$7.96 million | Q2 2015: -$7.63 million | Q3 2015: -$8.08 million | Q1 2016: -$7.92 million | Q2 2016: -$8.04 million | Q3 2016: -$9.32 million | Q1 2017: -$7.08 million | Q2 2017: -$6.54 million | Q3 2017: -$6.00 million | Q1 2018: -$5.04 million | Q2 2018: -$5.29 million | Q3 2018: -$1.93 million | Q1 2019: -$6.31 million | Q2 2019: -$3.54 million | Q3 2019: -$22.77 million | Q1 2020: -$3.94 million | Q2 2020: -$3.61 million | Q3 2020: -$10.47 million | Q1 2021: -$7.08 million | Q2 2021: -$25.95 million | Q3 2021: -$10.76 million | Q1 2022: -$19.02 million | Q2 2022: -$21.48 million | Q3 2022: -$23.91 million | Q1 2023: -$17.33 million | Q2 2023: -$23.07 million | Q3 2023: -$11.72 million | Q1 2024: -$11.92 million | Q2 2024: -$15.28 million | Q3 2024: -$12.97 million | Q1 2025: -$15.35 million | Q2 2025: -$14.74 million | Q3 2025: -$20.05 million.
• Over the full 12 years of available data (2014 to 2025), Ocugen, Inc.'s Net Income Loss has declined by 197.7%.
• Historical annual values: Fiscal year 2025: -$67.85 million | Fiscal year 2024: -$54.05 million | Fiscal year 2023: -$63.08 million | Fiscal year 2022: -$86.80 million | Fiscal year 2021: -$58.37 million | Fiscal year 2020: -$21.82 million | Fiscal year 2019: -$20.24 million | Fiscal year 2018: -$18.22 million | Fiscal year 2017: -$26.41 million | Fiscal year 2016: -$16.21 million | Fiscal year 2015: -$32.02 million | Fiscal year 2014: -$22.79 million.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026